Predicting the development of gastric cancer from combining Helicobacter pylon antibodies and serum pepsinogen status: a prospective endoscopic cohort study

Watabe, H.; Mitsushima, T.; Yamaji, Y.; Okamoto, M.; Wada, R.; Kokubo, T.; Doi, H.; Yoshida, H.; Kawabe, T.; Omata, M.
June 2005
Gut;Jun2005, Vol. 54 Issue 6, p764
Academic Journal
Background and aim: Helicobacter pylon infection and gastric atrophy are both risk factors for gastric cancer. We aimed to elucidate the natural history of gastric cancer development according to H pylon infection and gastric atrophy status. Subjects and methods: A total of 9293 participants in a mass health appraisal programme were candidates for inclusion in the present prospective cohort study: 6983 subjects revisited the follow up programme. Subjects were classified into four groups according to serological status at initial endoscopy. Group A (n = 3324) had "normal" pepsinogen and were negative for H pylon antibody; group B (n =2134) had "normal" pepsinogen and were positive for H pylon antibody; group C (n =1082) had "atrophic" pepsinogen and were positive for H pylon antibody; and group D (n =443) had "atrophic" pepsinogen and were negative for H pylon antibody. Incidence of gastric cancer was determined by annual endoscopic examination. Results: Mean duration of follow up was 4.7 years and the average number of endoscopic examinations was 5.1. The annual incidence of gastric cancer was 0.04% (95% confidence interval (CI) 0.02-0.09), 0.06% (0.03-0.13), 0.35% (0.23-0.57), and 0.60% (0.34-1.05) in groups A, B, C, and D, respectively. Hazard ratios compared with group A were 1.1(95% CI 0.4-3.4), 6.0 (2.4-14.5), and 8.2(3.2-21.5) in groups B, C, and D, respectively. Age, sex, and "group" significantly served as independent valuables by multivariate analysis. Conclusions: The combination of serum pepsinogen and anti-H pylon antibody provides a good predictive marker for the development of gastric cancer.


Related Articles

  • Validity of Serum Pepsinogen I/II Ratio for the Diagnosis of Gastric Epithelial Dysplasia and Intestinal Metaplasia during the Follow-Up of Patients at Risk for Intestinal-Type Gastric Adenocarcinoma. Dinis-Ribeiro, Mário; Da Costa-Pereira, Altamiro; Lopes, Carlos; Barbosa, Joana; Guilherme, Mateus; Moreira-Dias, Luís; Lomba-Viana, Helena; Silva, Rui; Abreu, Nuno; Lomba-Viana, Rafael // Neoplasia;Sep/Oct2004, Vol. 6 Issue 5, p449 

    A cohort of individuals (n = 136) with lesions as severe as atrophic chronic gastritis (ACG) was cross-sectionally evaluated for the validity assessment of pepsinogen I (PGI) and pepsinogen II (PGII) serum levels for the diagnosis of intestinal metaplasia (IM) and gastric dysplasia. PGI/PGII...

  • H. pylori and gastric atrophy are predictive markers for cancer.  // Nursing Standard;6/29/2005, Vol. 19 Issue 42, p19 

    Reports on the role of the combination of serum pepsinogen and anti-Helicobacter pylori as predictive markers for the development of gastric cancer based from a study in Japan. Consideration of H. pylori and gastric atrophy as risk factors for such cancer; Investigation of the natural history of...

  • Human T Lymphotropic Virus Type 1 Infection and Gastric Cancer Development in Japan. Matsumoto, Satohiro; Yamasaki, Kazumi; Tsuji, Kenichiro; Shirahama, Satoshi // Journal of Infectious Diseases;7/1/2008, Vol. 198 Issue 1, p10 

    Background. The rate of human T lymphotropic virus type 1 (HTLV-1) positivity among residents of Kamigoto, Japan, is extremely high (15%). Although the rate of Helicobacter pylori positivity in Kamigoto is almost the same as that in other areas of Japan, the incidence of gastric cancer in...

  • Circulating Anti-Helicobacter pylori Immunoglobulin A Antibodies and Low Serum Pepsinogen I Level Are Associated with Increased Risk of Gastric Cancer. Aromaa, Arpo; Kosunen, Timo U.; Knekt, Paul; Maatela, Jouni; Teppo, Lyly; Heinonen, Olli P.; Härkönen, Matti; Hakama, Matti K. // American Journal of Epidemiology;1996, Vol. 144 Issue 2, p142 

    Helicobacter pylori infection has been suggested to be associated with an increased risk of gastric cancer, and low levels of serum pepsinogen I (PG I) have been linked to atrophic gastritis, which is a risk factor for gastric cancer. In Finland, 39,268 persons from 25 cohorts participated...

  • IgG antibodies may have a role in H Pylori screening.  // Modern Medicine;Jan99, Vol. 67 Issue 1, p29 

    Discusses the abstract `Can Screening for lgG Antibodies Against Helicobacter Pylori be Used in Clinical Practice? Omit Endoscopy in Seropositive or Seronegative Patients?' by B.F.M. Werdmuller, V. Der Putten, et al.

  • Prognostic significance of genotyping Helicobacter pylon infection in patients in younger age groups with gastric cancer. Tiwari, S. K.; Manoj, G.; Vasanth Kumar, G.; Sivaram, G.; Hassan, S. I.; Prabhakar, B.; Devi, U.; Jalaluddin, S.; Kumar, K.; Ahmed, S.; Abid, Z.; Habeeb, M. A.; Khan, A. A.; C. M. Habibullah // Postgraduate Medical Journal;Apr2008, Vol. 84 Issue 990, p193 

    Malignant tumours of the stomach are common, but the incidence of stomach cancer varies from country to country, probably a result of genetic, epigenetic and environmental factors. Stomach cancer often occurs in older people whose stomachs produce only small quantities of acid. Although...

  • Does Concern About Missing Malignancy Justify Endoscopy in Uncomplicated Dyspepsia in Patients Aged Less Than 55? Gillen, Derek; McColl, Kenneth E. L. // American Journal of Gastroenterology;Jan1999, Vol. 94 Issue 1, p75 

    Objective: There is increasing interest in using noninvasive H. pylori testing rather than endoscopy in determining the management of younger patients presenting with dyspepsia. However, there is concern that this approach may result in missing potentially curable malignancy, The aim of the...

  • Helicobacter pylori eradication may prevent future gastric carcinomas. Ilson, David H. // Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p18 

    The article focuses on a study which found that removing Helicobacter pylori following endoscopic resection of early gastric cancer may be effective in preventing the development of metachronous gastric carcinoma. Researchers from Japan randomly assigned patients to Helicobacter pylori...

  • The Serum Pepsinogen Test as a Predictor of Gastric Cancer. Oishi, Yoshinori; Kiyohara, Yutaka; Kubo, Michiaki; Tanaka, Keiichi; Tanizaki, Yumihiro; Ninomiya, Toshiharu; Doi, Yasufumi; Shikata, Kentaro; Yonemoto, Koji; Shirota, Tomoko; Matsumoto, Takayuki; Iida, Mitsuo // American Journal of Epidemiology;Apr2006, Vol. 163 Issue 7, p629 

    The authors examined whether a serum pepsinogen test (SPT) based on the combination of the serum pepsinogen I level and pepsinogen I/II ratio is a good predictor of gastric cancer occurrence in a general Japanese population. A total of 2,446 subjects aged ≥40 years were classified into...


Read the Article


Sign out of this library

Other Topics